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The Clean Air Act (1) mandates that
National Ambient Air Quality Standards be
set to protect the most sensitive members of
the population. Children with asthma are
such a sensitive subpopulation. The relation-
ship between asthma and outdoor air pollu-
tants is of great interest. Special interest is
centered on the effects of particulate matter
(PM) air pollution because the U.S.
Environmental Protection Agency (U.S.
EPA) is attempting to change its PM regula-
tions. Although common outdoor air pollu-
tants have not been shown to cause asthma, as
documented in a recent review (2), PM air
pollution levels have been associated with a
broad spectrum of measures of asthma aggra-
vation. These adverse health effects include
pulmonary function decrements, visits to
emergency departments and hospital admis-
sions, and increased medication use. Few
studies have shown an association between
PM and increases in asthma symptoms. In a
study in Southern California, Delﬁno et al.
(3) found that PM air pollution was
associated with both symptoms and medica-
tion use in a panel of 25 children with asth-
ma. The children with the most baseline
symptoms were most at risk for aggravation
associated with PM. Vedal et al. (4) reported
that increased cough, phlegm production,
and sore throat were associated with PM < 10
µm in aerodynamic diameter (PM10) in chil-
dren with asthma in Port Alberni, British
Columbia, Canada, during an 18-month
period. Gielen et al. (5) reported an associa-
tion between black smoke (a marker of diesel
exhaust) and acute respiratory symptoms in a
panel of 61 children in the Netherlands.
Romieu et al. (6) found that an increase of
20 µg/m3 PM10 was associated with an 8%
increase in lower respiratory symptoms in 5-
to 7-year-old children.
More studies have found an association
between gaseous pollutants, such as sulfur
dioxide and nitrogen dioxide, and symp-
toms in children with asthma. For instance,
asthma symptoms and medication use have
been associated with air pollution levels in a
number of different geographical locations
such as Paris, France (7), where the strongest
relationship was between asthma aggravation
and SO2 concentrations on the same day,
and Sweden (8), where the strongest associa-
tion was seen with NO2. Von Mutius et al.
(9) studied 1,854 children (9–11 years of
age) with asthma. This questionnaire study
reported increased risks of developing upper
respiratory symptoms in winter months asso-
ciated with mean SO2 concentrations [odds
ratio (OR) = 1.72; 95% conﬁdence interval
(CI), 1.19–2.49], mean NOx concentrations
(OR = 1.53; 95% CI, 1.01–2.31), and PM
maximum values (OR = 1.62; 95% CI,
1.08–2.45). A combined pollutant metric
showed the highest risk (OR = 2.10; 95%
CI, 1.30–3.37). Peters et al. (10) found a
strong association between both peak flow
and symptom scores in children with asthma
with average SO2 and sulfate concentrations
in Germany. Some studies used trafﬁc indi-
cators (traffic density or distance from a
thoroughfare) as a surrogate for air pollu-
tion. Such studies have found that these traf-
ﬁc indicators are associated with signiﬁcant
increases in adverse respiratory outcomes in
children with asthma (11,12). 
In this study, we attempted to assess the
effects of air pollution on daily symptoms of
asthma aggravation in children on an individ-
ual level in Seattle, Washington. The children
in the study are enrolled in the Childhood
Asthma Management Program (CAMP) (13)
and thus are well-characterized asthmatics.
Seattle is in an air shed where SO2 concentra-
tions are very low and are not expected to
aggravate asthma, as seen in the European
studies (7–10). Previous studies have shown
that PM air pollution in Seattle is associated
with both increased visits to emergency
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Articles
We observed a panel of 133 children (5–13 years of age) with asthma residing in the greater Seattle,
Washington, area for an average of 58 days (range 28–112 days) during screening for enrollment in
the Childhood Asthma Management Program (CAMP) study. Daily self-reports of asthma symp-
toms were obtained from study diaries and compared with ambient air pollution levels in marginal
repeated measures logistic regression models. We deﬁned days with asthma symptoms as any day a
child reported at least one mild asthma episode. All analyses were controlled for subject-speciﬁc
variables [age, race, sex, baseline height, and FEV1 PC20 concentration (methacholine provocative
concentration required to produce a 20% decrease in forced expiratory volume in 1 sec)] and
potential time-dependent confounders (day of week, season, and temperature). Because of variable
observation periods for participants, we estimated both between- and within-subject air pollutant
effects. Our primary interest was in the within-subject effects: the effect of air pollutant excursions
from typical levels in each child’s observation period on the odds of asthma symptoms. In single-
pollutant models, the population average estimates indicated a 30% [95% conﬁdence interval
(CI), 11–52%] increase for a 1-ppm increment in carbon monoxide lagged 1 day, an 18% (95%
CI, 5–33%) increase for a 10-µg/m3 increment in same-day particulate matter < 1.0 µm (PM1.0),
and an 11% (95% CI, 3–20%) increase for a 10-µg/m3 increment in particulate matter < 10 µm
(PM10) lagged 1 day. Conditional on the previous day’s asthma symptoms, we estimated 25%
(95% CI, 10–42%), 14% (95% CI, 4–26%), and 10% (95% CI, 3–16%) increases in the odds of
asthma symptoms associated with increases in CO, PM1.0, and PM10, respectively. We did not
ﬁnd any association between sulfur dioxide (SO2) and the odds of asthma symptoms. In multipol-
lutant models, the separate pollutant effects were smaller. The overall effect of an increase in both
CO and PM1.0 was a 31% (95% CI, 11–55%) increase in the odds of symptoms of asthma. We
conclude that there is an association between change in short-term air pollution levels, as indexed
by PM and CO, and the occurrence of asthma symptoms among children in Seattle. Although
PM effects on asthma have been found in other studies, it is likely that CO is a marker for vehicle
exhaust and other combustion by-products that aggravate asthma. Key words: ambient air pollu-
tion, asthma, carbon monoxide, children, panel study, particulate matter, sulfur dioxide, symp-
toms, within-subject effects. Environ Health Perspect 108:1209–1214 (2000). [Online 20
November 2000]
http://ehpnet1.niehs.nih.gov/docs/2000/108p1209-1214yu/abstract.htmldepartments for asthma (14,15) and hospital
admissions for asthma (16). 
Methods
CAMP is a National Heart, Lung, and Blood
Institute-sponsored multicenter, randomized
clinical trial involving seven cities in the
United States: Albuquerque, New Mexico;
Baltimore, Maryland; Boston, Massachusetts;
Denver, Colorado; San Diego, California;
Seattle; St. Louis, Missouri; and one in
Canada (Toronto). Its main goal is to evaluate
the long-term effects of daily inhaled anti-
inﬂammatory medication on lung growth in
children diagnosed with mild to moderate
persistent asthma (13). We used data
obtained before randomization (i.e., before
the introduction of study medicine); these
data were collected in the calendar period
November 1993 through August 1995.
Participants were children living in the greater
Seattle area (133 of the 144 randomized at
Seattle). Before randomization, each child
completed questionnaires and visits; begin-
ning with the second screening visit, each
child received a daily diary card as well. The
average number of days of diary data provided
by each child before randomization was 58
(range 28–112 days). In the CAMP Air
Pollution Ancillary Study, we matched the
pre-randomization data with atmospheric
data from the Puget Sound Clean Air Agency. 
Study population. Children enrolled in
CAMP were 5–12 years of age at the initial
interview. They had a history of chronic mild
to moderate asthma on the basis of one or
more of the following for at least 6 months in
the previous year: suffered from asthma
symptoms more than once per week; used an
inhaled bronchodilator twice or more per
week, or needed asthma medication daily. 
Study participants completed a pre-ran-
domization screening period of 5–16 weeks.
CAMP obtained informed consent, and
questionnaires about demographic character-
istics, asthma history, and home environment
were completed. At the second screening
visit, all anti-asthma medication except res-
cue albuterol was stopped, and children were
asked to complete a diary card daily begin-
ning that day. They recorded peak ﬂow and
symptoms for 28 days to conﬁrm eligibility.
A child’s asthma was considered too mild if
there were fewer than 8 days during the 28-
day screening period with either a symptom
score of at least 1 on a 0–3 scale or morning
or evening peak ﬂow < 80% of personal best,
or if the sensitivity to methacholine [metha-
choline provocative concentration required
to produce a 20% decrease in forced expira-
tory volume in 1 se (FEV1 PC20) concentra-
tion] was greater than 12.5 mg/mL. A child’s
asthma was considered too severe if, during
the 28-day screening period, more than 8
puffs of albuterol were used on 3 consecutive
days, if night awakening due to asthma aver-
aged more than 1.5 times per week, if the
mean diary card symptom score was > 2, or if
he/she used medication other than albuterol
to control asthma. Children who still quali-
fied underwent three more visits in which
additional baseline data were collected. 
Asthma monitoring. The diary cards were
completed daily each morning and evening by
study participants. They recorded their morn-
ing and evening peak expiratory flow rate
(PEFR), their use of medications (rescue
inhaler and before exercise), whether they had
night awakening due to asthma, and a symp-
tom rating. We focused on a dichotomy of
the symptom rating that distinguished
between no asthma symptoms and at least
one mild asthma symptom (including wheez-
ing, coughing, chest tightness, and/or short-
ness of breath). We also obtained baseline
covariate information including age, sex, race,
height, weight, and FEV1 PC20 concentra-
tion, a measure of bronchial hyperresponsive-
ness based on a methacholine challenge test.
Ambient air monitoring. Atmospheric
data for the CAMP period November 1993
through August 1995 were provided by the
Puget Sound Clean Air Agency for 6, 3, and
1 monitoring sites, respectively, measuring
the daily carbon monoxide, atmospheric par-
ticles [PM; both by gravimetric reference
methods (PM10) and from nephelometers
(PM1.0)], and SO2 in the greater Seattle area.
No measurements of oxides of nitrogen were
available during this period. CO and PM1.0
were available throughout all 580 study days.
PM10 was not monitored by any of the three
sites on 16 study days, and SO2 was not
measured on 12 study days. The monitors
are operated according to national guidelines
set by the U.S. EPA. We converted the light
scattering measurements from nephelome-
ters to gravimetric units for ease of reporting
because previous studies have shown neph-
elometer measurements capture ﬁne PM in
the greater Seattle air shed (17). We also
obtained average air temperature from three
sites. We used daily averages of CO, PM,
and air temperature measurements to reduce
the variability of measurements among sites
and to better track the usual exposures for
the region as a whole.
Statistical analysis. We used repeated-
measures logistic regression models to
account for the correlation among the
repeated observations of the outcome vari-
able. Specifically, we applied a marginal
approach [generalized estimating equations
(GEE) with an exchangeable working corre-
lation matrix (18,19)] to estimate the popu-
lation-averaged effect of air pollution on
asthma symptoms, and a transition approach
(20) to estimate the population-averaged
effect conditioned on the previous day’s out-
come. We regressed the binary asthma
symptom outcome on each exposure of
interest, adjusting for subject-specific vari-
ables (age, race, sex, baseline height, and
FEV1 PC20 concentration) and potential
time-dependent confounders (six indicators
for day of week, linear splines of season,
temperature lagged 2 days, and its quadratic
term) with the Stata statistical package (21).
Because children who experienced asthma
symptoms on 1 day were probably more
likely than those who did not to have asthma
symptoms on the next day, the past history
of asthma symptoms might significantly
inﬂuence the present occurrence of asthma
symptoms. Therefore, in the transition
approach, we explicitly modeled the current
asthma symptom as a function of the past
response by including asthma symptoms
reported on the previous day as an additional
explanatory variable in the GEE model. We
performed simple graphic checks examining
residuals obtained from each model to assess
how well our models ﬁtted the study data.
Two types of residuals were considered:
residuals aggregated over all observations for
each study participant (residuals per person),
and residuals aggregated over all observations
assembled on each study day (residuals per
day). There was little evidence of any study
participant or study day being inﬂuential. 
In addition to analyzing the effect of air
pollutants separately as linear terms by ﬁtting
individual pollutant in the model, we also
considered multipollutant models in which
CO, SO2, and one type of PM were ﬁtted
simultaneously. Because we had no a priori
knowledge of which lags of air pollutants
were clinically relevant to the risk of days
with asthma symptoms, we examined the
same-day, 1-day, and 2-day lags of air pollu-
tion levels and selected the ones with the
strongest association with asthma symptom
days to include in the multipollutant models.
We report the joint effects of the odds of
asthma symptoms for a simultaneous change
in two pollutants by adding the effects of
both in the linear predictor with all other
covariates held constant. The standard error
is adjusted for the covariance of the two esti-
mates by using a standard variance calcula-
tion for the sum of correlated variables.
Unlike many air pollution panel studies,
we observed children at various times and in
different seasons. Because we compared dif-
ferent children at different time points, dif-
ferences in between- and within-subject air
pollution effects were possible. Naïve applica-
tion of the repeated measures logistic regres-
sion models implicitly assumes that the two
effects are identical. We therefore explicitly
separated these two components by fitting
the between-subject (long-term) air pollutant
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i (subject mean of air pollution
concentration), and the within-subject
(short-term) air pollutant exposure, Xit-X
__
i
(deviation of daily air pollution level from
subject mean air pollution level), in the mod-
els simultaneously (22). Because our objec-
tive was to evaluate the short-term effects of
acute exposure on children with asthma, the
within-subject air pollution effects are of
interest. We do not report the between-sub-
ject effects because of concerns about residual
between-subject confounding.
Results
There was a total of 7,658 pre-randomization
daily diary records collected over 580 days
between 3 November 1993 and 15 August
1995. Figure 1 summarizes by date the num-
ber of daily diary records provided by study
participants. By protocol, each child com-
pleted a minimum of 28 days of records
before randomization. As many as 112 days
and an average of 58 days of records were
collected from each child. Except for the 17
January 1995 through 28 March 1995 peri-
od when the clinic suspended recruitment
activities, a range of 1–28 and an average of
13 diary records were collected per study day.
As shown in Table 1, the average age of
children at randomization was 8.6 years, with
an average age of 3.2 years when asthma was
conﬁrmed by a doctor. Twenty-four percent
were from ethnic minorities and 20% had
household incomes below $30,000. On aver-
age the group was very responsive to metha-
choline challenge (mean FEV1 PC20 = 1.5
mg/mL) and all participants were responsive
(maximum 12.2 mg/mL). All baseline char-
acteristics were comparable between boys and
girls in the study population (p > 0.05). 
Table 2 summarizes the asthma-related
events that the children reported on the
diary card. All 133 children had had at least
one mild asthma symptom on at least one
day during the pre-randomization period.
Thirteen of them had experienced at least one
mild asthma episode on a daily basis. Most
children (53%) had at least one night awak-
ening for asthma, but overall, it only occurred
on 8% of the diary record days. This is con-
sistent with using too many night awakenings
because of asthma as an exclusion criterion for
randomization. Most participants also report-
ed using rescue inhalers before exercise (78%)
or for asthma signs (99%).
The air pollutant exposure levels and air
temperature during the study period are
summarized in Table 3. The air pollutant
levels over 580 study days were all fairly low.
The highest CO level (4.18 ppm) was
observed during December 1994; this was
the only day during the study when the CO
level was > 4 ppm. Most of the CO levels
were well below 3 ppm. PM concentrations
were highest and most variable in the ﬁrst 3
months of the study (November 1993 to
January 1994); however, most of the mea-
surements were < 60 µg/m3. SO2 levels were
low throughout the entire study period, with
a range of 1–21 ppb. During the 580-day
study period, CO and PM levels were highly
correlated, whereas SO2 was only weakly
correlated with other pollutants, as shown in
Table 3.
Among the same-day to 2-day lags of air
pollutant exposure, we found the 1-day lag
CO and PM10 levels and the same-day PM1.0
and SO2 levels to have the strongest effects
on asthma symptoms after controlling for
subject-speciﬁc variables and time-dependent
confounders. Table 4 shows the estimated
odds of asthma symptoms for a unit increase
in the within-subject pollutant exposure (1
ppm for CO, 10 µg/m3 for PM, and 10 ppb
for SO2) from each of the regression models.
We found an association between an increase
in short-term air pollution levels and asthma
Articles • Air pollution and asthma
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Figure 1. Number of daily diary records collected during the CAMP pre-randomization study period.
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Table 1. Summary of baseline characteristics for 133 Seattle children in the CAMP pre-randomization period.
Total (n = 133) Male (n = 84) Female (n = 49)
Characteristics Percent Mean ± SD Percent Mean ± SD Min Max Percent Mean ± SD Min Max
Age (years) 8.6 ± 2.1 8.7 ± 2.1 5.1 13.0 8.5 ± 2.1 5.1 13.1
Age asthma conﬁrmed (years) 3.2 ± 2.4 3.1 ± 2.3 0.2 10.0 3.5 ± 2.4 0.2 11.0
Duration of asthma (years) 5.4 ± 2.7 5.6 ± 2.8 0.2 11. 7 4.9 ± 2.6 0.5 10.7
Standing height (cm) 132.3 ± 13.7 132.9 ± 14.4 100.2 171.9 131.4 ± 12.7 105.1 157.5
Weight (kg) 32.3 ± 11.3 33.1 ± 12.6 14.2 73.0 31.0 ± 8.9 18.0 53.0
FEV1 PC20 (mg/mL) 1.54 ± 2.18 1.39 ± 1.95 0.03 10.70 1.80 ± 2.53 0.061 12.20
Race
White (non-Hispanic) 76 74 80
Black 7 8 6
Other 17 18 14
Family income
< $15,000 5 6 4
$15,000–$29,999 15 14 16
$30,000–$49,999 38 37 39
At least $50,000 39 39 39
Decline to answer 3 4 2
Abbreviations: Max, maximum; Min, minimum.symptoms for CO and PM, but not for SO2.
In the single-pollutant marginal (GEE) mod-
els, we found a 30% increase in the odds for
a child to experience at least one asthma
symptom for a 1 ppm increment in short-
term CO, 18% and 11% increases for 10
µg/m3 increments in short-term PM1.0 and
PM10, respectively. The effects of air pollu-
tant exposure were reduced in the transition
models but were still elevated with the odds
of symptoms relative to no symptoms esti-
mated at 1.25 for CO lagged 1 day (95% CI,
1.10–1.42), 1.14 for same-day PM1.0 (95%
CI, 1.04–1.26), and 1.10 for PM10 lagged 1
day (95% CI, 1.03–1.16). This result is con-
ditional on the previous day’s symptoms,
which were strongly associated with the cur-
rent day’s symptoms: the relative odds of any
asthma symptoms given symptoms on the
previous day was 4.6 in all transition models
(95% CI, 3.6–5.9). Although previous day’s
symptoms was a strong predictor of current
day’s symptoms, it did not confound the air
pollution–asthma association. The magni-
tudes of the air pollutant effects were
essentially the same in both marginal and
transition models with their conﬁdence inter-
vals overlapped. We examined all two-way
interactions between the short-term air pollu-
tion level and each of the adjustment vari-
ables, but did not ﬁnd any important effects.
This included previous day’s symptoms in
the transition model, indicating that the air
pollution effect on symptoms did not depend
upon recent symptoms.
When these short-term pollutant effects
were considered in the multipollutant models,
all pollutant effects decreased. Only CO
remained statistically important (Table 4).
The effect of PM was no longer elevated after
adjusting for other pollutants (CO and SO2;
marginal model 95% CI for PM1.0,
0.98–1.26; 95% CI for PM10, 0.95–1.19).
With both PM1.0 and SO2 held constant, a 1
ppm increase in CO inﬂated the odds of asth-
ma symptoms by 18% (17% in the transition
model). We also considered the joint effect of
a simultaneous change in both CO and PM
(1 ppm increment in CO and 10 µg/m3
increment in PM1.0), with SO2 held constant.
For a simultaneous change in both CO and
PM1.0, we estimated the effect at 1.31-fold in
the marginal model (95% CI, 1.11–1.55) and
1.26-fold in the transition model (95% CI,
1.11–1.44). For CO and PM10, the effect was
1.22-fold in the marginal model (95% CI,
1.05–1.43) and 1.19-fold in the transition
model (95% CI, 1.02–1.39).
Discussion
In this panel study of children with asthma,
increased exposure to air pollutants, speciﬁ-
cally CO and PM, was associated with
increased odds of at least one mild asthma
symptom. SO2 was not associated with the
odds of asthma symptoms. Although SO2 is
known to aggravate asthma, our SO2 result is
not surprising given its low concentration in
Seattle. In contrast, CO is not known to
aggravate asthma. Although we have also
found CO effects on asthma in a previous
analysis of asthma hospital admissions in
Articles • Yu et al.
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Table 2. Summary of diary records: experience of the 133 subjects during the CAMP pre-randomization
study period.
No. (%) of subjects Mean ± SD Minimum Maximum
Event
At least 1 asthma episode during the day 133 (100)a 0.6 ± 0.3b 0.03 1.0
At least 1 asthma episode daily 13 (10)
Night awakening for asthma 71 (53) 0.08 ± 0.07 0.01 0.36
Absent from school for asthma 30 (23) 0.03 ± 0.02 0.01 0.09
Contacted doctor for asthma 21 (16) 0.03 ± 0.02 0.01 0.07
Medication
Rescue inhaler before exercise (puffs/day) 104 (78)c 0.8 ± 0.9d 0.02 4.0
Rescue inhaler for asthma sign or low 132 (99) 2.0 ± 1.4 0.13 6.5
PEFR (puffs/day)
Prednisone for asthma (pills/day) 8 (6) 0.3 ± 0.2 0.05 0.6
PEFR (L/min)
AM 7,458e 228.3 ± 69.9f 30 600
PM 7,488 244.0  ± 67.7 30 540
aNumber (%) of subjects ever having an event. bValues are the mean ± SD, minimum, and maximum of the fraction of
days for subjects who ever had an event. cNumber (%) of subjects ever taking medication.dValues are the mean ± SD,
minimum, and maximum of the average dose among subjects who had ever had medication. eNumber of records with
completed PEFR. fValues are the mean ± SD, minimum, and maximum PEFR over all completed records.
Table 3. Correlation among air pollutants and temperature over 580 study days.
Temperature (F) CO (ppm) PM1.0 (µg/m3)P M 10 (µg/m3)S O 2(ppb)
Percentiles
Minimum 26.3 0.65 2.03 7.67 1
Mean 52.4 1.6 10.4 24.7 7.26
Median 52.3 1.47 7.28 21 7
Maximum 78.3 4.18 61.7 86.3 21
Correlations
Temperature 1
CO –0.44 1
PM1.0 –0.48 0.82 1
PM10 –0.33 0.86 0.89 1
SO2 –0.07 0.31 0.31 0.38 1
Table 4. Percentiles of pollutants and estimates of odds ratios of asthma symptoms for a short-term 1 ppm
increase in CO, a 10 µg/m3 increase in PM, and a 10 ppb increase in SO2.
Odds ratio (95% conﬁdence interval)
Exposure Marginal GEE Transition GEE
Single-pollutant models
COit – 
__
COi (ppm)
Same day 1.22 (1.03, 1.45) 1.18 (1.02, 1.37)
1-Day lag 1.30 (1.11, 1.52) 1.25 (1.10, 1.42)
2-Day lag 1.26 (1.09, 1.46) 1.18 (1.04, 1.33)
PM1.0it – PM
___
1.0i (µg/m3)
Same day 1.18 (1.05, 1.33) 1.14 (1.04, 1.26)
1-Day lag 1.17 (1.04, 1.33) 1.13 (1.03, 1.24)
2-Day lag 1.09 (0.98, 1.21) 1.04 (0.96, 1.13)
PM10 it – PM
___
10i (µg/m3)
Same day 1.09 (1.01, 1.18) 1.08 (1.01, 1.15)
1-Day lag 1.11 (1.03, 1.20) 1.10 (1.03, 1.16)
2-Day lag 1.08 (1.01, 1.17) 1.05 (1.00, 1.11)
SO2 it – SO
__
2i (ppb)
Same day 1.07 (0.90, 1.27) 1.06 (0.90, 1.25)
1-Day lag 1.07 (0.90, 1.28) 1.06 (0.90, 1.26)
2-Day lag 1.00 (0.83, 1.20) 0.97 (0.81, 1.15)
Multipollutant models
Model 1
1-Day lag COit – 
__
COi 1.18 (1.03, 1.36) 1.17 (1.02, 1.35)
Same day PM1.0it – PM
___
1.0 i 1.11 (0.98, 1.26) 1.08 (0.96, 1.20)
Same day SO2it – SO
__
2i 1.00 (0.85, 1.19) 1.00 (0.85, 1.17)
Model 2
1-Day lag COit – COi
___
1.15 (0.92, 1.44) 1.13 (0.91, 1.41)
1-Day lag PM10it – PM
___
1.0i 1.06 (0.95, 1.19) 1.05 (0.95, 1.16)
Same day SO2it – SO
__
2i 1.02 (0.86, 1.21) 1.02 (0.87, 1.19)
i, indexes the individual; t, indexes day.Seattle (16), it is unlikely that CO itself is
causing the effects. Rather, ambient CO lev-
els, particularly when quantified by spatial
averaging, may be a good marker for ambi-
ent levels of combustion by-products that
aggravate asthma. 
Our PM results are consistent with ﬁnd-
ings from several previous studies. For exam-
ple, among 83 African-American children
with asthma 7 to 12 years of age in Los
Angeles, California, Ostro et al. (23) reported
a 9% increase in the reporting of shortness of
breath for a 10 µg/m3 increase in PM10.
Whittemore and Korn (24) found a 0.8%
increase in asthma attacks for a 10 µg/m3
increase in total suspended particulates in a
group of asthmatics residing in the Los
Angeles area. In both of these studies,
significant effects were also seen for ozone
concentrations. Pope et al. (25) studied a
school-based sample of 34 children who
wheezed and/or were diagnosed with asthma
by a doctor; the authors reported a 5.1%
increase in lower respiratory disease including
trouble breathing, dry cough, and wheezing
for a 10 µg/m3 increase in PM10. Similar
findings were obtained by Vedal et al. (4),
who reported an 8% increase in the odds of
cough in a group of children with physician-
diagnosed asthma. No association between
PM10 and respiratory symptoms was found
in non-asthmatic children, suggesting that
children with asthma are more susceptible to
adverse health effects of air pollution. 
The CAMP Air Pollution Ancillary
Study provided an excellent opportunity to
investigate the air pollution–asthma relation-
ship. During this pre-randomization phase of
the trial, all participants suspended mainte-
nance medications; therefore, this study is
unique in its ability to evaluate the acute
effects of air pollution without any con-
founding effects of routine preventive thera-
py. The extensive repeated within-subject
data increased power for detection of any sig-
niﬁcant air pollution effects on children with
asthma by comparing each child with himself
or herself. In addition, collecting diary infor-
mation on each child on a daily basis reduced
possible recall bias. We controlled for season-
al confounding in two ways: a) we explicitly
included seasonal adjustment terms in the
model, and b) we partitioned air pollution
exposure into within-subject and between-
subject exposures so that we did not make
the implicit assumption that the two effects
were identical. In many air pollution panel
studies, the variation in exposure between
individuals is controlled by designs stipulat-
ing that all individuals are observed over
identical time periods (however, missing data
invariably negate much of this design advan-
tage). We found that the magnitudes of the
two exposure effects were quite different,
which further conﬁrmed to us the necessity
for separating air pollutant effects explicitly.
We did not report the between-subject
exposure effects because we believe they may
be biased by residual between-subject
confounding.
There are several potential sources of bias
that we should consider in interpreting our
results. Although recall biases were unlikely
given the data collection protocol, there
might have been biases due to misreporting of
an asthma episode on a given day. Asthma
symptom ascertainment was only based on
the subjective reporting by each child, with-
out any clinical validation. However, because
participating children and their parents were
not aware that we were studying air pollution,
their perceptions of air pollution conditions
were unlikely to inﬂuence their reporting of
asthma symptoms. In addition, the individual
pollutant exposures could have been misclassi-
fied in this study because we substituted a
regional average from ambient monitors for
individual exposures. This may be particularly
problematic for CO because these monitors
are located in street canyons in Seattle where
they are likely to pick up high levels of CO
from vehicle exhaust. To compensate for this
as much as possible, we used an average of six
monitors to dampen the influence of local
effects. Because previous research has shown
that the street canyon monitors are correlated
with more generally distributed “background”
levels in Seattle (26), we believe the spatial
average captures the important source of vari-
ation for this study—the day-to-day variation
in CO levels. Furthermore, we had no infor-
mation such as time–activity data to adjust
individual participants’ pollutant exposures.
The actual air pollutant exposure level to
ambient source pollutants for each study child
is a function of the amount of time they spent
outdoors, the pollutant-speciﬁc penetration
rate, and building ventilation characteristics.
PM has been shown to penetrate readily into
a sample of homes in Seattle (27), and CO is
also known to penetrate well. For these pollu-
tants, ambient monitor measurements may
reasonably represent personal exposure to
their ambient source components. We also
did not adjust for nonambient-source time-
varying exposures such as cigarette smoke,
indoor combustion from cooking and heat-
ing, or household sensitizing antigens.
Because nonambient-source PM is indepen-
dent of ambient-source PM over time (28),
these exposures were unlikely to have intro-
duced bias in our models. Finally, we were
unable to consider other potential time-vary-
ing confounders and effect modiﬁers such as
other outdoor pollutants, exposure to air-
borne pollens and molds, other meteorologic
factors, and respiratory infections. We omit-
ted rescue inhaler use related to asthma
because we felt that it was an intermediate
variable, but it could also be considered as a
confounder. 
We examined several lags of air pollutants
in the analyses before selecting the ﬁnal mod-
els. Because we had no prior clinical knowl-
edge of which lags of air pollutants should be
evaluated in relation to asthma symptoms, we
selected the one for each air pollutant that
demonstrated the strongest statistical associa-
tion with asthma outcome. We considered
lags up to 2 days to allow for both immediate
acute effects and the delayed effects caused by
build-up of late phase reactivity. However
there is possible bias in this approach due to
model selection. In a simulation study based
on Seattle data, Lumley and Sheppard (29)
showed that the potential for bias from this
model selection strategy is not negligible. This
model selection bias is smallest when the true
association is moderately large. Because 
the magnitude of the true association is
unknown, we cannot rule out some bias due
to model selection in the present analyses.
In conclusion, we found that symptoms
of asthma aggravation in a population of
children with mild to moderate asthma were
associated with air pollutants known to be
emitted from combustion sources. The chil-
dren in this study were a selected group and
were all under a physician’s care for asthma;
thus they probably differ in this respect from
the population of children reporting to hos-
pital emergency departments for asthma
symptoms. These results for daily symptoms
complement the other Seattle-area studies
that found air pollution health effects for
emergency department visits (12,13) and
hospital admissions (14). Taken together,
these studies suggest that the health effects
among asthmatics from short-term changes
in air pollution levels are an important public
health problem.
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